How Biosimilar Drug Approvals Provide Opportunities for Pharmacists

Fred Eckel, RPh, MS, Editor-in-Chief of Pharmacy Times, reflects on how pharmacists will be affected by FDA approvals of biosimilars.

Fred Eckel, RPh, MS, Editor-in-Chief of Pharmacy Times, reflects on how pharmacists will be affected by FDA approvals of biosimilars.

This video was recorded at APhA’s Annual Meeting and Exposition in March 2015.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.